CIK: 1790610 - Address: 620 Lesher Place, Lansing, MI 48912
28 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/17/23 10:06
10/13/23
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS-515.1000-127D
10/12/23 11:25
10/11/23
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS-3015.690-2-726D
12/28/21 17:41
12/23/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.d-2944.910-1-321D
12/28/21 17:41
12/23/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.d2031.3501321D
9/30/21 18:10
9/30/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.d-69943.720-16-4420D
9/30/21 18:10
9/30/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.d32420.2301640020D
5/4/21 16:04
5/3/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVP,InterS-3496.7300-310D
4/14/21 18:07
4/13/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVP,InterS-9292.250-1-910D
2/8/21 14:31
2/5/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVP,InterS-19385.230-2-1711D
1/7/21 08:14
1/6/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVP,InterS.d-91482.910-11-4514D
1/7/21 08:14
1/6/21
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVP,InterM.d79863.33013999%14D
11/18/20 18:13
11/16/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVP,InterS.d-1,05373.230-14-5412D
11/18/20 18:13
11/16/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVP,InterM.d64740.4601612D
10/22/20 08:41
10/21/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.d-47170.620-7-3910D
10/22/20 08:41
10/21/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.d23635.340717810D
8/7/20 10:40
8/5/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.d-45580.080-6-3510D
8/7/20 10:40
8/5/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.d35662.700612010D
5/7/20 17:24
5/5/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS-5764.000-1-810D
2/14/20 17:11
2/14/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.d-51772.750-7-3911D
2/14/20 17:11
2/14/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.d48360.430824311D
2/12/20 15:29
2/10/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.d-49870.010-7-4110D
2/12/20 15:29
2/10/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.d29541.460721710D
2/7/20 16:50
2/5/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.dm-37670.020-5-3410D
2/7/20 16:50
2/5/20
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.dm19636.490510610D
11/25/19 08:57
11/21/19
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.d-16264.610-3-1910D
11/25/19 08:57
11/21/19
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.d8835.34033210D
10/17/19 18:24
10/16/19
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPM.d11929.71046210D
10/17/19 18:24
10/16/19
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticLilly Jason WarrenMIOVPS.d-18365.890-3-2110D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact